Patents by Inventor Peter J. Maurer

Peter J. Maurer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 6117871
    Abstract: The subject invention relates to methods of treating alpha-2 adenoreceptor modulated disorders, comprising administration, to a mammal in need of such treatment, of a safe and effective amount of a compound having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and(b) R' is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; and halo.The subject invention also relates compounds and compositions for preventing or treating of disorders modulated by alpha-2 adrenoreceptors.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: September 12, 2000
    Assignee: The Procter & Gamble Company
    Inventors: Peter J. Maurer, Raymond T. Henry, Russell James Sheldon
  • 2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 5965595
    Abstract: The subject invention relates to compounds having the structure: ##STR1## wherein (a) n is an integer from 1 to about 3;(b) X and Y are each independently selected from O, S and CH.sub.2, with at least one of X and Y being O or S;(c) R is unsubstituted, straight or branched chain alkanyl or alkanoxy having from 1 to about 3 non-hydrogen atoms; and(d) R' is selected from hydrogen, methyl, cyano, and halo;pharmaceutical compositions containing such compounds; and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: October 12, 1999
    Assignee: The Procter & Gamble Company
    Inventors: Peter J. Maurer, Jeffrey J. Ares, William L. Seibel, Daniel P. Walker, Russell James Sheldon, Raymond T. Henry
  • 2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 5914342
    Abstract: The subject invention relates to compounds having the structure: ##STR1## wherein (a) n is an integer from 1 to about 3;(b) X and Y are each independently selected from O, S and CH.sub.2, with at least one of X and Y being O or S;(c) R is unsubstituted, straight or branched chain alkanyl or alkanoxy having from 1 to about 3 non-hydrogen atoms; and(d) R' is selected from hydrogen, methyl, cyano, and halo; pharmaceutical compositions containing such compounds; and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.
    Type: Grant
    Filed: September 24, 1998
    Date of Patent: June 22, 1999
    Assignee: The Procter & Gamble Company
    Inventors: Peter J. Maurer, Jeffrey J. Ares, William L. Seibel, Daniel P. Walker, Russell James Sheldon, Raymond T. Henry
  • 6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor agonists
    Patent number: 5804587
    Abstract: The subject invention relates to compounds having the structure: ##STR1## as defined in the claims, and to pharmaceutical compositions containing such compounds, and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: September 8, 1998
    Assignee: The Procter & Gamble Company
    Inventors: Thomas Lee Cupps, Peter J. Maurer, Jeffrey J. Ares, Raymond T. Henry, Russell James Sheldon, Glen E. Mieling, Sophie E. Bogdan
  • 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
    Patent number: 5578607
    Abstract: The subject invention relates to compounds having the structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl;(b) R' is selected from unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; and halo; and(c) R" is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; methyl monosubstituted with hydroxy, thiol or amino; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; amino; unsubstituted amide; unsubstituted or C.sub.1 -C.sub.3 substituted amido; halo; unsubstituted sulfoxide; unsubstituted sulfonyl; and cyano;pharmaceutical compositions containing such compounds, and the use of such compounds for preventing or treating respiratory, ocular, and/or gastrointestinal disorders.
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: November 26, 1996
    Assignee: The Procter & Gamble Company
    Inventors: Thomas L. Cupps, Peter J. Maurer, Jeffrey J. Ares